US CDC officials ask states to prepare to distribute COVID-19 vaccines in late October

US Centre for Disease Control and Prevention (CDC) has asked state public health officials, to prepare and distribute a potential coronavirus vaccine to high-risk groups as soon as October, documents published by ncy showed.  Previously, American health officials h asserted that a vaccine for coronavirus might be approved without even completing full trials leaving WHO concerned.

Re: Moderna's COVID-19 Vaccine: 13,194 People Enroll For Phase 3 Trials

Re: White House Deunces WHO's Concern About COVID-19 Vaccine Release

A CDC report published earlier in New York Times revealed that ncy h contacted officials in all 50 American states and five large cities with planning information. As per report, CDC was rey to distribute one or two vaccines in limited quantities by late October. Time has become an important factor in vaccine development and distribution, especially during time when Americans heing towards elections.

Billions of dollars invested 

Currently, Moderna Inc, AstraZeneca Plc and Pfizer are leing in race to develop a safe and effective vaccine. However, President Trump, who has promised a vaccine before elections h alrey invested billions of federal funds under Operation Warp speed in various companies like Johnsons and Johnsons. According to reprots,   $1.6 billion funding grant to vavax Inc. has emerged as biggest contribution me to a single company under Operation Warp Speed.

As per vavax Inc.'s statement, funds will allow company to test a viable vaccine candidate by this fall.  firm furr ded that it has around 30,000 subjects who have agreed to take part in trials. Earlier in May, vavax Inc also received $338 million from Coalition for Epidemic Preparedness Invations.

Re: White House Deunces WHO's Concern About COVID-19 Vaccine Release

Meanwhile, WHO officials said moving too quickly to make a vaccine widely available could pose risks. "If you move too quickly to vaccinate ... millions of people, you may miss certain verse effects," said Mike Ryan, he of WHO's emergencies program. Ar WHO expert, Soumya Swaminathan, meanwhile said that FDA's approach was "t something that you do very lightly."  Though global health ncy has touted an early release of vaccine, it has also stated that great care must be taken and untested drugs and vaccines should t be approved lightly.

Re: US Grants $1.6 Billion To vavax For COVID-19 Vaccine Project Under Operation Warp Speed

 Im credits:AP